Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnston Press PLC Regulatory News (JPR)

  • There is currently no data for JPR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI)

14 Nov 2018 09:26

RNS Number : 3237H
Liberum Capital Limited
14 November 2018
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Liberum Capital Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Johnston Press plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Johnston Press plc

(d) Date dealing undertaken:

13th November 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

Ordinary 1P

 

 

Purchase

 

8320

 

0.03688 GBP

 

0.03688 GBP

 

Ordinary 1P

 

 

Sale

 

50231

 

0.0395 GBP

 

0.0395 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

14th November 2018

Contact name:

Harriet Blackie

Telephone number:

020 3100 2012

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERGCBDBDDBBGIS
Date   Source Headline
22nd Jan 20094:35 pmRNSPrice Monitoring Extension
6th Jan 20094:03 pmRNSBlocklisting Interim Review
6th Jan 20093:54 pmRNSTotal Voting Rights
5th Jan 20098:56 amRNSBoard Change
22nd Dec 20085:27 pmRNSDirector/PDMR Shareholding
22nd Dec 20085:25 pmRNSHolding(s) in Company
19th Dec 20085:42 pmRNSHolding(s) in Company
19th Dec 20082:32 pmRNSDirector/PDMR Shareholding
18th Dec 20085:32 pmRNSHolding(s) in Company
18th Dec 200812:13 pmRNSDirector/PDMR Shareholding
15th Dec 200810:16 amRNSHolding(s) in Company
4th Dec 20084:04 pmRNSHolding(s) in Company
1st Dec 20083:27 pmRNSTotal Voting Rights
27th Nov 20084:45 pmRNSHolding(s) in Company
25th Nov 20084:51 pmRNSDirector/PDMR Shareholding
24th Nov 20089:27 amRNSDirector/PDMR Shareholding
21st Nov 20084:03 pmRNSHolding(s) in Company
21st Nov 20089:49 amRNSDirector/PDMR Shareholding
12th Nov 20087:00 amRNSInterim Management Statement
4th Nov 20083:07 pmRNSInterim Management Statement Notification
31st Oct 20084:40 pmRNSPrice Monitoring Extension
31st Oct 20082:05 pmRNSTotal Voting Rights
21st Oct 20083:17 pmRNSDirector/PDMR Shareholding
6th Oct 20084:49 pmRNSSecond Price Monitoring Extn
6th Oct 20084:38 pmRNSPrice Monitoring Extension
1st Oct 20083:11 pmRNSDirector/PDMR Shareholding
30th Sep 20082:37 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSBoard Appointment
22nd Sep 20085:35 pmRNSHolding(s) in Company
19th Sep 20084:38 pmRNSPrice Monitoring Extension
19th Sep 20082:25 pmRNSDirector/PDMR Shareholding
1st Sep 20084:38 pmRNSTotal Voting Rights
27th Aug 20087:00 amRNSInterim Results
21st Aug 20082:55 pmRNSDirector/PDMR Shareholding
14th Aug 20083:55 pmRNSHolding(s) in Company
12th Aug 20087:00 amRNSNotice of Results
5th Aug 200812:18 pmRNSHolding(s) in Company
4th Aug 20084:44 pmRNSSecond Price Monitoring Extn
4th Aug 20084:38 pmRNSPrice Monitoring Extension
31st Jul 200811:50 amRNSTotal Voting Rights
29th Jul 200810:15 amRNSHolding(s) in Company
29th Jul 200810:13 amRNSHolding(s) in Company
29th Jul 200810:11 amRNSHolding(s) in Company
24th Jul 200812:08 pmRNSHolding(s) in Company
21st Jul 20085:16 pmRNSDirector/PDMR Shareholding
7th Jul 20082:49 pmRNSDirector/PDMR Shareholding
7th Jul 20082:20 pmRNSBoard Appointment
4th Jul 200811:58 amRNSHolding(s) in Company
1st Jul 20085:31 pmRNSBlocklisting Interim Review
1st Jul 20085:25 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.